SG11202001720RA - Liquid dosage forms of imatinib - Google Patents
Liquid dosage forms of imatinibInfo
- Publication number
- SG11202001720RA SG11202001720RA SG11202001720RA SG11202001720RA SG11202001720RA SG 11202001720R A SG11202001720R A SG 11202001720RA SG 11202001720R A SG11202001720R A SG 11202001720RA SG 11202001720R A SG11202001720R A SG 11202001720RA SG 11202001720R A SG11202001720R A SG 11202001720RA
- Authority
- SG
- Singapore
- Prior art keywords
- imatinib
- dosage forms
- liquid dosage
- liquid
- forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201721026519 | 2017-07-26 | ||
| IN201823010403 | 2018-03-21 | ||
| PCT/IB2018/055583 WO2019021229A1 (fr) | 2017-07-26 | 2018-07-26 | Formes galéniques liquides d'imatinib |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202001720RA true SG11202001720RA (en) | 2020-03-30 |
Family
ID=63517936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202001720RA SG11202001720RA (en) | 2017-07-26 | 2018-07-26 | Liquid dosage forms of imatinib |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20200206223A1 (fr) |
| EP (1) | EP3658190A1 (fr) |
| CN (1) | CN111278466A (fr) |
| AU (1) | AU2018306149B2 (fr) |
| RU (1) | RU2020108342A (fr) |
| SG (1) | SG11202001720RA (fr) |
| WO (1) | WO2019021229A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021009686A1 (fr) | 2019-07-15 | 2021-01-21 | Intas Pharmaceuticals Ltd. | Composition pharmaceutique d'imatinib |
| EP4171512A1 (fr) * | 2020-06-24 | 2023-05-03 | Novartis AG | Formulations liquides orales de ruxolitinib |
| RU2755094C1 (ru) * | 2020-11-12 | 2021-09-13 | Общество С Ограниченной Ответственностью "Научно-Производственная Компания "Фармасофт" | Лекарственная форма для инъекций в виде раствора и стабилизатор для его приготовления |
| CA3198046A1 (fr) * | 2020-11-17 | 2022-05-27 | David W. Osborne | Compositions et procedes pour l'administration de medicaments par voie intradermique profonde |
| CN114159387B (zh) * | 2021-12-10 | 2022-08-19 | 江苏汉晨药业有限公司 | 一种氢溴酸右美沙芬口服溶液 |
| WO2024063770A1 (fr) * | 2022-09-21 | 2024-03-28 | Kadmon Corporation, Llc | Formulation liquide à base de belumosudil |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006035204A2 (fr) | 2004-09-27 | 2006-04-06 | Astrazeneca Ab | Polytherapie |
| US7767688B2 (en) | 2005-06-03 | 2010-08-03 | Novartis Ag | Combination of pyrimidylaminobenzamide compounds and imatinib for treating gastrointestinal stromal tumours |
| EA015102B1 (ru) | 2005-06-03 | 2011-06-30 | Элан Фарма Интернэшнл Лтд. | Препараты наночастиц мезилата иматиниба |
| EP2009008A1 (fr) | 2006-10-26 | 2008-12-31 | Sicor, Inc. | Base d'imatinib, et mesylate d'imatinib et son procédé de préparation |
| CN101641345A (zh) * | 2006-10-26 | 2010-02-03 | 西科尔公司 | 晶体和无定形伊马替尼碱、甲磺酸伊马替尼及其制备方法 |
| US20100087444A1 (en) | 2007-03-12 | 2010-04-08 | Dr. Reddy's Laboratories Ltd. | Imatinib mesylate |
| CA2856692C (fr) | 2011-11-24 | 2016-06-28 | Imuneks Farma Ilac Sanayi Ve Ticaret A.S. | Formes posologiques solides a base d'imatinib reconstituees juste avant l'utilisation |
| WO2014041551A1 (fr) * | 2012-09-14 | 2014-03-20 | Natco Pharma Limited | Formulation comprenant de l'imatinib sous la forme d'une solution orale |
| JP2016521283A (ja) * | 2013-05-06 | 2016-07-21 | スカラー ロック インコーポレイテッドＳｃｈｏｌａｒ Ｒｏｃｋ，Ｉｎｃ． | 成長因子モジュレーションのための組成物および方法 |
| EP3019159A4 (fr) | 2013-07-09 | 2017-01-18 | Shilpa Medicare Limited | Compositions pharmaceutiques orales comprenant du mésylate d'imatinib |
-
2018
- 2018-07-26 SG SG11202001720RA patent/SG11202001720RA/en unknown
- 2018-07-26 EP EP18765721.8A patent/EP3658190A1/fr active Pending
- 2018-07-26 RU RU2020108342A patent/RU2020108342A/ru not_active Application Discontinuation
- 2018-07-26 AU AU2018306149A patent/AU2018306149B2/en not_active Expired - Fee Related
- 2018-07-26 US US16/633,048 patent/US20200206223A1/en not_active Abandoned
- 2018-07-26 WO PCT/IB2018/055583 patent/WO2019021229A1/fr unknown
- 2018-07-26 CN CN201880062828.6A patent/CN111278466A/zh active Pending
- 2018-07-26 US US16/634,475 patent/US11957681B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20200206223A1 (en) | 2020-07-02 |
| EP3658190A1 (fr) | 2020-06-03 |
| CN111278466A (zh) | 2020-06-12 |
| US11957681B2 (en) | 2024-04-16 |
| WO2019021229A1 (fr) | 2019-01-31 |
| AU2018306149B2 (en) | 2021-09-16 |
| RU2020108342A (ru) | 2021-08-26 |
| US20220160709A1 (en) | 2022-05-26 |
| AU2018306149A1 (en) | 2020-03-12 |
| RU2020108342A3 (fr) | 2021-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287437A (en) | Flavociclib solid dosage forms | |
| ZA201901590B (en) | Liquid pharmaceutical composition | |
| SG11202001720RA (en) | Liquid dosage forms of imatinib | |
| ZA201901736B (en) | Liquid pharmaceutical composition | |
| IL275457A (en) | Spiro exo-aza inhibitors of the MENIN-MLL interaction | |
| IL285882A (en) | Medicinal uses for l–4–chlorokynurenine | |
| PT3218033T (pt) | Nebulização de líquidos | |
| PL3544416T3 (pl) | Nanoszenie cieczy | |
| IL272934A (en) | Pharmaceutical compositions containing a high dose of pridopidine | |
| GB2548424B (en) | Liquid pharmaceutical composition of clonidine | |
| GB201906717D0 (en) | Electronic liquid despenser | |
| GB201718468D0 (en) | Stable liquid pharmaceutical compositions of bortezomb | |
| PL3061371T3 (pl) | Podłoga prysznicowa | |
| IL269169A (en) | New dosage form | |
| HK1246146A1 (zh) | 用於治療真菌病的藥物組合物 | |
| GB201720793D0 (en) | Stable liquid formulations of pemetrexed | |
| GB201721386D0 (en) | Chrondogy of time-wave | |
| GB201714772D0 (en) | Dosage forms of therapeutic compounds | |
| TWM533204U (en) | Improved structure of liquid level sensor | |
| IL253572A0 (en) | A liquid pharmaceutical preparation | |
| GB201608353D0 (en) | Integration of electronic devices | |
| TWM533036U (en) | Improved structure of container | |
| GB201516697D0 (en) | Serillization of liquids | |
| GB201604432D0 (en) | Liquid gold | |
| GB201512635D0 (en) | Uses of therapeutic compounds |